Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 5 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               75.02               60.26           289.50    
                   (+24.5 pct)         (-2.4 pct)       (+0.3 pct)  
  Operating            9.39                8.32            20.00    
                   (+12.8 pct)         (+2.0 pct)       (-5.4 pct)  
  Recurring           11.12                7.65            23.00    
                   (+45.3 pct)         (-37.3 pct)      (-6.0 pct)  
  Net                  6.06               11.01            13.00    
                   (-44.9 pct)         (-19.6 pct)      (-35.6 pct) 
  EPS               75.98 yen          137.91 yen       162.89 yen  
  EPS Diluted       75.89 yen          137.77 yen                   
  Ann Div                              110.00 yen       100.00 yen  
  -Q2 div                               50.00 yen        50.00 yen  
  -Q4 div                               60.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news